Back to All Peptides

Ipamorelin / CJC-1295 (No DAC)

The classic growth-hormone stack in one vial.

Human clinical evidenceStudied in one or more human clinical trials, but not FDA-approved for this use. Evidence quality and trial size vary — see sources.

For research purposes only. These products are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm these products will be used for legitimate research purposes.

About Ipamorelin / CJC-1295 (No DAC)

This blend pairs Ipamorelin, a selective growth-hormone secretagogue, with CJC-1295 (No DAC), a short-acting GHRH analogue. The two act on different receptors to amplify a clean, pulsatile release of growth hormone without significantly raising cortisol or prolactin. It is one of the most widely used GH-optimization combinations, convenient as a single reconstituted vial.

Key Benefits

  • Amplifies natural pulsatile GH release
  • Two complementary mechanisms in one injection
  • Supports recovery, sleep, and body composition
  • Minimal impact on cortisol and prolactin

Set a goal (top of the page) to see how Ipamorelin / CJC-1295 (No DAC) scores against it, and what the better-evidenced alternatives are.

Category Ratings

Muscle & Strength
Good
Fat Loss
Mild
Recovery
Good
Skin & Anti-Aging
Minimal
Sleep
Good
Cognitive
N/A
Immune
Minimal
Longevity
Mild
Bone & Hormonal
N/A

How to Take

Injection

Subcutaneous injection on an empty stomach, morning and/or before bed

Common Side Effects

  • Water retention
  • Injection site reactions
  • Head rush / flushing
  • Tingling in extremities

Legal & Regulatory Status

Research use only. Not FDA-approved. No studies exist on this specific combination; the evidence tier reflects the individual components (ipamorelin, CJC-1295), which have only limited human GH-PK data.

Safety and regulatory details for FDA-approved compounds are drawn from the official product label via openFDA; clinical development status reflects ClinicalTrials.gov. This information is provided for research reference, is not endorsed by the FDA, and may not be complete or current.

Research & Sources

Human clinical evidenceStudied in one or more human clinical trials, but not FDA-approved for this use. Evidence quality and trial size vary — see sources.

No citations available. We could not locate indexed peer-reviewed literature for this compound specifically. That absence is the reason for its evidence rating — treat any claims about it, including ours, with corresponding caution.

Ipamorelin / CJC-1295 (No DAC)

Prices at quality-checked sources · as of August 2026 (3 weeks ago)

Observed on each vendor’s public listing — see how these sources are vetted. Peptide Concierge doesn’t sell peptides and isn’t affiliated with any vendor; confirm current pricing at the source.

CategoryRecovery
Formsinjectable

Builds a working set shared across the stack builder, calculator, scheduler and compare.